Vaso-Occlusive Crisis clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

    open to eligible people ages 12 years and up

    This study consists of two parts: phase 2 (Part A) and phase 3 (Part B). It is a multicenter study designed to evaluate the safety, effectiveness, and pharmacokinetics (PK) of CSL889 (human hemopexin) when given intravenously (IV) to adults and adolescents with sickle cell disease (SCD) experiencing vaso-occlusive crises (VOC). The main objectives of the study are to assess how CSL889 affects the time it takes for VOC to resolve in participants with SCD, and to evaluate the safety and tolerability of CSL889 in study participants.

    at UC Irvine

  • Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease

    Sorry, in progress, not accepting new patients

    This study is an open-label study to evaluate the safety of long-term administration of inclacumab in participants with sickle cell disease (SCD). Participants in this study will have completed a prior study of inclacumab.

    at UC Irvine

Last updated: